Brief: Jilin Province Huinan Changlong Bio-Pharmacy Posts Qtrly Profit Attributable RMB18.9 Million
April 24 (Reuters) - Jilin Province Huinan Changlong
Bio-pharmacy Co Ltd 8049.HK :
* QTRLY TURNOVER RMB160.5 MILLION VERSUS RMB153.1 MILLION
* QTRLY PROFIT ATTRIBUTABLE TO EQUITY HOLDERS RMB18.9
MILLION
VERSUS RMB17.9 MILLION
* ON 24 APRIL 2018, A SPECIAL DIVIDEND OF RMB7 CENTS PER
SHARE WAS
PROPOSED
Source text for Eikon: ID:nHKS40lw3H
Further company coverage: 8049.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jilin Province Huinan Changlong Bio-pharmacy Co
See all newsBrief: Jilin Province Huinan Changlong Bio-Pharmacy Profit For Year Attributable Rmb198.9 Million
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes To ICBC Structured Deposit Product
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes To ICBC Wealth Management Product For RMB50 MLN
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes To ICBC Wealth Management Product
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes To ICBC Wealth Product For RMB50 MLN